---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-116216"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T00:40:43.437545+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bio-Path Holdings raises $2.0M in registered direct offering with common warrants

## Summary
- Sold 800,000 shares at $2.50/share for gross proceeds ~$2.0M; net proceeds ~$1.7M after fees and expenses.
- Issued common warrants to buy 800,000 shares at $2.85; exercisable after 6 months, term 5.5 years.
- ROTH Capital Partners acted as placement agent; cash fee of 7.0% of gross proceeds plus expense reimbursement up to $50,000.
- Proceeds intended for working capital and general corporate purposes; closing expected November 9, 2022.

## SEC filing metadata
- accession: 0001104659-22-116216
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000110465922116216/0001104659-22-116216-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000110465922116216/tm2230081d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-116216
- JSON: https://secwatch.observer/filing/0001104659-22-116216.json
- Plain text: https://secwatch.observer/filing/0001104659-22-116216.txt

## Key facts
- Material Agreements
  BIO-PATH HOLDINGS, INC. entered into Purchase Agreements with several institutional and accredited investors valued at gross proceeds of approximately $2.0 million (effective 2022-11-06).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: several institutional and accredited investors
  - Value: gross proceeds of approximately $2.0 million
  - Effective: 2022-11-06
  source text: On November 6, 2022, Bio-Path Holdings, Inc. (the “Company”) and several institutional and accredited investors entered into securities purchase agreements (the “Purchase Agreements”), pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 800,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $2.50 and gross proceeds of approximately $2.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000110465922116216/0001104659-22-116216-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.